Rajwinder Lehal
Has grant
Chief Executive Officer
SwitzerlandResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors.
Open Date: 2020-04-01
Close Date: 2022-04-01
Grant: Close
Development of a proprietary biomarker based companion diagnostic for identification and selection of cancer patients with disease driven by NOTCH pathway activation, for treatment with Cellestia`s first-in-class pan NOTCH inhibitor and clinical development candidate drug CB-103.
Open Date: 2017-03-01
Close Date: 2019-02-01
Grant: Close
Anti-cancer efficacy and mode of action dissection of a novel first-in class inhibitor of the Notch pathway.
Open Date: 2015-05-01
Close Date: 2016-11-01
Articles (3)
Year:
2021
Year:
2020
Year:
2020
Collaborators (1)
Ute Koch
EPFL (École Polytechnique Fédérale de Lausanne)
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.